squamous cell carcinoma of the head and neck

Showing 1 - 25 of 150

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +10 more
  • Regular care with additional administration of a semi-structured interview
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Sep 13, 2023

HLA-DR in Cell Cultures Isolated From Primary Squamous Cell

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Cancer
  • cell culture
  • Roma, Lazio, Italy
    Fondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023

Colorectal Tumors, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial (SGN-EGFRd2)

Not yet recruiting
  • Colorectal Neoplasms
  • +3 more
  • (no location specified)
Aug 1, 2023

Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • (no location specified)
Jul 3, 2023

Breast Cancer, Lung Cancer, Colorectal Cancer Trial in Kobe (e-PRO monitoring)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • e-PRO monitoring
  • Kobe, Hyogo, Japan
    Kobe University Graduate School
Jun 27, 2023

Squamous Cell Carcinoma of the Head and Neck, Paclitaxel, Carboplatin Trial in Amiens (GCP intratumoral catheter)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +3 more
  • intratumoral catheter
  • Amiens, Picardie, France
    CHU Amiens Picardie
Apr 26, 2023

NSCLC, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Duarte (JANX008)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Mar 29, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Shanghai (MRG003, Cetuximab injection, Methotrexate Injection)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Feb 21, 2023

Melanoma, NSCLC Trial in United States (brentuximab vedotin, pembrolizumab)

Recruiting
  • Melanoma
  • +2 more
  • Tucson, Arizona
  • +31 more
Jan 20, 2023

Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla (Ibrutinib 560mg PO daily (Imbruvica),

Active, not recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Ibrutinib 560mg PO daily (Imbruvica)
  • +2 more
  • La Jolla, California
    UCSD Moores Cancer Center
Jan 11, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Portland (Intratumoral Ipilimumab)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Intratumoral Ipilimumab
  • Portland, Oregon
    Portland Providence Medical Center
Jan 8, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in United States (SNS-301, Pembrolizumab)

Terminated
  • Squamous Cell Carcinoma of the Head and Neck
  • San Francisco, California
  • +9 more
Dec 6, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Ann Arbor (Cisplatin, Carboplatin, IMRT (Intensity-Modulated Radiation

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Ann Arbor, Michigan
  • +1 more
Dec 20, 2022

Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,

Active, not recruiting
  • Cancer of Head and Neck
  • +5 more
  • MK-3475 (neoadjuvant)
  • +6 more
  • Boston, Massachusetts
  • +2 more
Dec 9, 2022

Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, NSCLC Trial in Worldwide (Lifileucel, LN-145, Pembrolizumab)

Recruiting
  • Metastatic Melanoma
  • +2 more
  • Lifileucel
  • +5 more
  • La Jolla, California
  • +44 more
Dec 16, 2022

Squamous Cell Carcinoma of the Head and Neck, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Boston (Interleukin-15

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Interleukin-15 Superagonist (N-803)
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 2, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Stanford ([18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • [18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.
  • Stanford, California
    Stanford Hospital and Clinics
Dec 1, 2022

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Triple Negative Breast Cancer, Renal Cell Cancer, High Grade Ovarian Serous Adenocarcinoma Trial in United Kingdom

Recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Modi-1/Modi-1v
  • +2 more
  • Brighton, Default, United Kingdom
  • +13 more
Nov 18, 2022

Squamous Cell Carcinoma of the Head and Neck, Anal Canal Cancer, Cervical Cancer Trial in France (biological, procedure, other,

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +2 more
  • Blood sample collection
  • +4 more
  • Besançon, France
  • +4 more
Nov 17, 2022

NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in Lexington (Immune checkpoint inhibitor, Radiation Therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Immune checkpoint inhibitor
  • Radiation Therapy
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 10, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (Monalizumab, Cetuximab)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Tucson, Arizona
  • +126 more
Oct 21, 2022

Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Non-small-cell Lung Cancer
  • +5 more
  • PF-07209960
  • Duarte, California
  • +11 more
Oct 10, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in United States (Dalantercept)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Dalantercept
  • Aurora, Colorado
  • +7 more
Sep 13, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (Nivolumab, Cetuximab, Methotrexate)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Stanford, California
  • +63 more
Sep 6, 2022